AstraZeneca logo

US Medical Head, Dyslipidemia

AstraZeneca

Wilmington, DEHybridPosted 3 days ago
Full TimeDirector & AboveMedical AffairsPharmaceutical
Original posting ↗

Summary

The US Head of Medical – Dyslipidemia is a leadership position that reports directly to the VP Medical Cardiovascular Renal Metabolism (CVRM), within the BioPharmaceuticals Business Unit's US Medical CVRM franchise. The successful candidate will lead a team to develop product and disease area strategies and drive product launches for our novel oral PCSK9 inhibitor across the life-cycle.

Job description

What you'll do:

  • Build and lead the dyslipidemia medical team, with accountability for the development and execution of disease area and brand strategies and plans
  • Accountable for disease area and brand budget and resource requirements
  • Partner effectively with the Commercial Lead, role-modeling effective teamwork across the enterprise
  • Effectively act as the US point of contact for the Global Product Team (GPT)
  • Provide the US viewpoint into life-cycle management/phase IV strategy and study design
  • Develop and maintain positive relationships with key external and internal customers
  • Anticipate future trends and needs in the marketplace
  • Coach, mentor and performance lead direct reports and take an active role in succession and talent management
  • Develop and foster a team culture that encourages continued growth and recognition
  • Collaborate and build internal and external networks
  • Deliver results in a sophisticated matrix environment, building capabilities, and leading large scale impactful medical initiatives
  • Lead the launch of new products
  • Leverage AI and digital driven analytics, platforms and clinical solutions to improve medical planning, scientific engagement, evidence generation and patient outcomes
  • Ensure compliance with all AZ corporate policies

Requirements for the role:

  • Sophisticated Scientific Degree (MBBS, PharmD, PhD, or MD) or equivalent education
  • A minimum of 7 years of experience in the pharmaceutical industry, ideally in Medical Affairs and in the dyslipidemia space
  • A minimum of 5 years of experience leading high performing teams in the pharmaceutical industry
  • Medical/clinical/scientific expertise in CVRM
  • US Regulatory Strategy Knowledge/Experience, including new product approval, labeling requirements/negotiations
  • Strong business acumen, with comprehensive understanding of the U.S. healthcare environment

Desirable Skills/Experience

  • Phase 3b/4 and post-approval dedication research including leading all aspects of patient registries and REMS programs
  • Translational medicine, population-based real-world research
  • Bridging with coordinated care management & Quality improvement pathways
  • Understanding of Health Outcomes Research including Patient-reported outcomes
  • Experience integrating emerging technologies—such as AI-supported insights, machine learning tools, or digital medical platforms—into medical affairs strategies or operational processes

Requirements

  • Sophisticated Scientific Degree (MBBS, PharmD, PhD, or MD) or equivalent education
  • A minimum of 7 years of experience in the pharmaceutical industry, ideally in Medical Affairs and in the dyslipidemia space
  • A minimum of 5 years of experience leading high performing teams in the pharmaceutical industry
  • Medical/clinical/scientific expertise in CVRM
  • US Regulatory Strategy Knowledge/Experience, including new product approval, labeling requirements/negotiations
  • Strong business acumen, with comprehensive understanding of the U.S. healthcare environment

Company overview

AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.